March 28, 2020

Neonatal intensive care respiratory devices market to exhibit productive growth during the forecast period

The latest market report published by Credence Research, Inc. “Neonatal Intensive Care Respiratory Devices MarketGrowth, Future Prospects, and Competitive Analysis 2019 – 2027

The neonatal intensive care respiratory devices market was valued at US$ 1,396.5 Mn in 2018 and expected to reach US$ 2,134.5 Mn by 2027 at a CAGR of 4.8% during the forecast period from 2019 to 2027.

Access Free Sample Copy of Research Report @ https://www.credenceresearch.com/sample-request/59707

Market Insights:

Neonatal Intensive Care Respiratory Devices Market

From 2019 to 2027, the global neonatal intensive care respiratory devices market is growing productively, accredited to the increase in infant admissions in clinics and NICUs along with increased prevalence of various respiratory disorders on a global scale. Advanced technology progression in the segment of ventilators, expansion in production together with demand for advanced devices in the segment of nebulizers and inhalers are driving global market growth.

Development of top quality neonatal intensive care respiratory devices with increased cost in the end user segment is also a major factor driving the overall growth. Partnerships with top manufacturers in the U.S. and Europe will further spur revenue growth during the forecast period. In April 2018, Vyaire Medical, Inc. (BD) acquired ACUTRONIC USA and in October 2018 Lifelines Neurodiagnostic Systems, Inc. acquired Incereb Ltd. Other major factors driving the market growth include increasing NICU hospitalizations, the predominance of medical services related to pneumonia, focal line-related circulatory system contaminations, and other neonatal emergency clinic gained infection or hospital acquired infection will further spur revenue growth during the forecast period.

Access Free Sample Copy of Research Report @ https://www.credenceresearch.com/sample-request/59707

Top manufactures are focusing on the supply and demand for new devices. Increasing number of acquisitions, and strategic agreements by key private players in the U.S market will drive the market growth. For instance, in Sep 2018, Philips in association with the Consortium for Affordable Medical Technologies industrialized an innovative resuscitation medical device called AIR, augmented infant resuscitator. It is a conventional neonatal bag-valve-mask resuscitator that efficiently give artificial respiration to asphyxiated newborn babies and helps decrease neonatal mortality. Nevertheless, the high cost of branded devices, burden of respiratory diseases with less treatment options in the developing regions, very less awareness along with less technology expansion are few factors restraining the growth of the neonatal intensive care respiratory devices market on a global scale.

Key Market Movements:

  • Globally, the neonatal intensive care respiratory devices market remains to show a lucrative growth with a CAGR of 4.8% for the period from 2019 to 2027
  • Asia Pacific market will grow expressively due to its improved infrastructure, very large patient pool and improved technology expansion in countries such as India,  China, Singapore, Indonesia, Malaysia and others
  • Increasing number of NICU hospitals and specialty clinics, adoption of branded neonatal intensive care respiratory devices, and increasing medical expenditure in the developing nations will drive the overall market growth
  • Major players in this vertical are GE Healthcare, Medtronic plc., C. R. Bard, Inc., Inspiration Healthcare Group plc, Getinge AB, Drägerwerk AG & Co. KGaA, Becton, Dickinson and Company, Cook Medical, Teleflex Incorporated, Trudell Medical International, Mercury Medical and others

Browse full report at https://www.credenceresearch.com/report/neonatal-intensive-care-respiratory-devices-market

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact:

Credence Research Inc

Name: Chris Smith (Global Sales Manager)

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web:  https://www.credenceresearch.com  

Leave a Reply

Your email address will not be published. Required fields are marked *